Veranova A CDMO that manages complexity with confidence

Veranova A CDMO that manages complexity with confidence

X

Overview of Risperidone

Product

Risperidone

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

55 API Suppliers, 30 USDMF, 19 CEP/COS, 7 JDMF, 12 EU WC, 34 KDMF, 18 NDC API, 26 Listed Suppliers

DEVELOPMENTS

15 Drug(s) in Development

15 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

11 Suppliers

11 Suppliers

DOSSIERs // Finished Dosage Formulations

1107 Dossiers, 210 FDA Orange Book, 509 Europe, 81 Canada, 114 Australia, 87 South Africa, 106 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.25MG, TABLET;ORAL - 0.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 3MG, TABLET;ORAL - 4MG, SOLUTION;ORAL - 1MG/ML, FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS - 120MG, FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS - 90MG, INJECTABLE;INTRAMUSCULAR - 12.5MG/VIAL, INJECTABLE;INTRAMUSCULAR - 25MG/VIAL, INJECTABLE;INTRAMUSCULAR - 37.5MG/VIAL, INJECTABLE;INTRAMUSCULAR - 50MG/VIAL, TABLET, ORALLY DISINTEGRATING;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.25MG
TABLET;ORAL - 0.5MG
TABLET;ORAL - 1MG
TABLET;ORAL - 2MG
TABLET;ORAL - 3MG
TABLET;ORAL - 4MG
SOLUTION;ORAL - 1MG/ML
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS - 120MG
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS - 90MG
INJECTABLE;INTRAMUSCULAR - 12.5MG/VIAL
INJECTABLE;INTRAMUSCULAR - 25MG/VIAL
INJECTABLE;INTRAMUSCULAR - 37.5MG/VIAL
INJECTABLE;INTRAMUSCULAR - 50MG/VIAL
TABLET, ORALLY DISINTEGRATING;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 41 Roquette, 39 Kerry, 25 BASF, 18 Microlex e.U, 18 SPI Pharma, 15 Gangwal Healthcare, 15 Corel Pharma Chem, 12 Sigachi Industries, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Gangwal Chemicals, 9 A&C by Aceto, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 DFE Pharma, 7 Ideal Cures Pvt Ltd, 7 Rochem International Inc, 7 Seppic, 6 Lonza Capsugel, 6 Vasa Pharmachem, 6 DKSH, 5 Prachin Chemical, 4 Pharmatrans-Sanaq, 4 ACG Worldwide, 2 Lubrizol Life Science Health, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Finar, 2 Alcedo Pharmachem, 2 Jai Radhe Sales, 2 Pfanstiehl, 2 Nomisma Healthcare, 2 Doshion Polyscience, 2 Qualicaps, 2 The Dow Chemical Company, 2 Aeon Procare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 NEWEDGE Overseas, 1 Minakem, 1 Clariant, 1 Evonik Industries, 1 Zhejiang Huakang Pharmaceutical, 1 Kima Chemical

EXCIPIENTS BY APPLICATIONS

95 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 42 Taste Masking, 40 Direct Compression, 40 Disintegrants & Superdisintegrants, 36 Thickeners and Stabilizers, 28 Controlled & Modified Release, 27 Granulation, 27 Lubricants & Glidants, 21 Chewable & Orodispersible Aids, 19 Solubilizers, 18 Topical, 18 Film Formers & Plasticizers, 16 Co-Processed Excipients, 9 Empty Capsules, 9 API Stability Enhancers, 9 Parenteral, 4 Vegetarian Capsules, 3 Rheology Modifiers, 2 Coloring Agents, 2 Emulsifying Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

33 US Medicaid Prescriptions, 406 Finished Drug Prices

MARKET PLACE

12 APIs, 9 DOSSIERS // FDF

PATENTS

38 US Patents, 32 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 4 Analytical Solutions, 3 EDQM Standards, 4 USP Standards, 7 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilations #Pharmaflow, 40 News

Related Products

Related Products

API SUPPLIERS

API Suppliers

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

Other Certificates

Other Suppliers

API REF. PRICE (USD / KG)

1,217

API Market Place

INTERMEDIATES

DOSSIERS // FDF

USA (Orange Book)

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

FDF Market Place

EXCIPIENTS

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

biophore-india-pharmaceuticals-pvt-ltd-m-2023-03-27

Access Virtual Booth

Contact Supplier

With bases around the World, there is no limit to our capabilities for Sourcing Materials & Services for the Pharmaceutical Industry.

Access Virtual Booth

Contact Supplier

Market Place

Home

Menu

Post Enquiry

Market Place

Search